Loading...
COMPASS Pathways plc
CMPS•NASDAQ
Healthcare
Medical - Care Facilities
$4.33
$-0.04(-0.92%)
COMPASS Pathways plc (CMPS) Financial Performance & Income Statement Overview
Review COMPASS Pathways plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-30.15%
↓ 30.15%
Net Income Growth
-30.94%
↓ 30.94%
Operating Cash Flow Growth
-22.40%
↓ 22.40%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-71.63%
↓ 71.63%
ROIC
-65.45%
↓ 65.45%
COMPASS Pathways plc (CMPS) Income Statement & Financial Overview
Review COMPASS Pathways plc's (CMPS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $63070.00 | $60965.00 |
| Gross Profit | $0.00 | $0.00 | -$63070.00 | -$60965.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $32.14M | $32.93M | $29.07M | $24.90M |
| SG&A Expenses | $16.27M | $14.97M | $14.25M | $13.67M |
| Operating Expenses | $48.41M | $47.90M | $43.32M | $38.57M |
| Total Costs & Expenses | $48.41M | $47.90M | $43.32M | $38.57M |
| Interest Income | $1.62M | $1.98M | $2.41M | $0.00 |
| Interest Expense | $1.13M | $1.14M | $1.11M | $1.10M |
| Depreciation & Amortization | $50000.00 | $59605.00 | $63070.00 | $60965.00 |
| EBITDA | -$41.13M | -$41.64M | -$39.55M | -$35.41M |
| EBITDA Ratio | ||||
| Operating Income | -$48.41M | -$47.90M | -$43.32M | -$38.57M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $6.11M | $9.57M | $5.40M | $3.61M |
| Income Before Tax | -$42.31M | -$38.33M | -$37.92M | -$34.97M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $1.02M | -$173000.00 | -$176000.00 | -$222000.00 |
| Net Income | -$43.33M | -$38.50M | -$38.10M | -$35.19M |
| Net Income Ratio | ||||
| EPS | -$0.63 | -$0.56 | -$0.56 | -$0.55 |
| Diluted EPS | -$0.63 | -$0.56 | -$0.56 | -$0.55 |
| Weighted Avg Shares Outstanding | $68.47M | $68.40M | $68.37M | $64.22M |
| Weighted Avg Shares Outstanding (Diluted) | $68.47M | $68.40M | $68.37M | $64.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan